Stock screener

MRVI

Broke outConviction 75LongHealthcareScan · Thu, Sep 24, 2026
Symmetrical triangleBullish engulfingtriangle

Maravai Lifesciences Holdings, Inc. (MRVI) closed at $7.65 (+3.80%) on Sep 24, 2026. It is in the "Broke out" lane with a symmetrical triangle pattern. Price is above its 50-day and above its 200-day moving average. RSI(14) 58, RS Rating 97, -15.0% from its 52-week high, +125.0% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

MRVI$7.65+3.80%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 2.54M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Trade plan

LongReward : Risk0.10
Entry
Entry
7.65
Risk
Stop
6.25
-18.4% to stop
Reward
Target 1
7.78
+1.8% to target
Stretch
Target 2
7.92
+3.5% to T2
Risk : reward balance
Risk to stopReward to target

Levels are derived from the pattern's structure (resistance, support and ATR) — a mechanical plan, not financial advice. Size positions to your own risk tolerance.

MARAVAI LIFESCIENCES HOLDINGS, INC.PHARMACEUTICAL PREPARATIONSwww.maravai.com ↗
Price7.65
Change+3.80%
Gap-0.75%
Rel volume1.17×
Avg volume2.95M
Avg $ vol21.45M
SMA 207.24
SMA 507.01
SMA 2004.73
Price vs 50+9.18%
Price vs 200+61.78%
MA stackbullish
50/200 cross—
Supertrenddown · 7.88
RSI (14)58
MACD hist0.02
MACD crossbull · 0d
Stoch %K / %D91 / 88
ADX (14)18
+DI / −DI29 / 18
RSI divergenceBearish
MACD divergence—
ATR %5.53%
ADR %4.93%
52w high9.00
52w low2.69
From 52w high-15.00%
Above 52w low+184.39%
New 52w highNo
SqueezeOff
Bollinger width22.91%
%B0.75
Donchian pos46.69%
Donchian high8.98
Donchian low6.49
AVWAP (52w high)7.45
vs AVWAP high+2.62%
AVWAP (52w low)5.28
vs AVWAP low+44.86%
OBV trendDown
Chaikin MF (20)-0.19
Today vs 20d1.17×
Avg vol (14d)2.54M
Avg vol (20d)2.95M
Avg $ vol (20d)21.45M
Market cap1.1B
RS Rating97 / 99
RS 3m (vs SPY)+20.51%
RS 6m (vs SPY)+129.16%
RS line new highNo
Trend template8/8
Technical rank84.1
1 week+5.23%
1 month-15.00%
3 months+25.00%
6 months+145.98%
1 year+179.20%
YTD+125.00%
P/E-8.44
P/B5.40
P/S5.95
P/FCF-15.62
EPS-0.9000
Div yield—
ROE-63.91%
ROA-21.66%
Debt/Eq0.72
Current4.05
EV/EBITDA—
Gross margin18.30%
Net margin-70.41%
Rev growth-28.34%
EPS growth9.72%
Price target7.50
Target upside-1.96%
Analyst ratingBuy
Institutional101.57%
Ent. value1.18B
Revenue51.44M
Net income-12.42M
Gross profit20.65M
Free cash flow-70.72M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out147.51M
Employees416
ListedFri, Nov 20, 2020
Free float117.94M
Float %80.6%
Short interest10.96M
Days to cover1.7d
Short volume53.5%
Squeeze score38 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.07 vs −$0.07
Last surprise0.0% beat
Setup gradeA
Conviction75 / 100
Pattern quality50%
Tech rank84.1 / 100
Group rank59 / 100
Status laneBroke out
Setup directionLong
Pattern familyTriangle
Resistance6.88
Support5.98
Days since event2d
Candle confirmBullish engulfing

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in MRVI

All disclosures →
No recent disclosed trades by Congress in MRVI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MRVI · open-market 2 sells

InsiderSideShares
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-09-08
Tax29.25K
Asarpota Rajesh
Chief Financial Officer · Class A Common Stock · 2026-08-31
Tax5.46K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-08-10
Tax29.25K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-07-08
Tax29.25K
ORESHACK KURT
General Counsel · Class A Common Stock · 2026-06-10
Sell25K
LUCIER GREGORY T
Director · Class A Common Stock · 2026-06-09
Gift46.29K
LUCIER GREGORY T
Director · Class A Common Stock · 2026-06-09
Gift46.29K
ORESHACK KURT
General Counsel · Class A Common Stock · 2026-06-09
Sell25K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-06-08
Tax351K
Brust Bernd
Chief Executive Officer · Class A Common Stock · 2026-06-08
Other—

SEC filings

EDGAR filings in MRVI · 8 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.